experimental group:CD22 CAR-T

2 trials

Sponsors

The General Hospital of Western Theater Command

Conditions

Acute B-lymphoblastic leukemiaB-cell lymphoma

Early Phase 1

Open clinical study on the safety and efficacy of immune cell therapy for adult recurrent refractory B-cell lymphoma

RecruitingChiCTR2200058606

The General Hospital of Western Theater CommandB-cell lymphoma

Start: 2022-05-01Updated: 2024-01-08

An open clinical study on the safety and efficacy of immune cell therapy for adult recurrent refractory acute B-lymphoblastic leukemia

RecruitingChiCTR2200059816

The General Hospital of Western Theater CommandAcute B-lymphoblastic leukemia

Start: 2022-05-01Updated: 2024-04-01

Related Papers

PB2499: BLINATUMOMAB SEQUENTIAL ANTI-CD22 CAR-T CELLS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SUCCESSFUL TREATMENT OF B LYMPHOBLASTIC LEUKEMIA EXTRAMEDULLARY RECURRENCE: A CASE REPORT

HemaSphere2023-08-01